Allerderm

Industry · 11 registered clinical trials.

Status	Trial	Phase	Started
Unknown	Metal Panel Allergen Patch Test Study Atopic Dermatitis Eczema	Phase 3	2022-02-07
Completed	Clinical Evaluation of Metal Panel Allergens: Dose Response Study Dermatitis, Eczematous	Phase 2	2016-12-05
Completed	Clinical Evaluation of Metal Panel Allergens: Mercury, Aluminum and Palladium Dose Response Study Contact Dermatitis	Phase 2	2013-11-04
Completed	Clinical Evaluation of Lyral® Dose Response Study Contact Dermatitis	Phase 2	2013-02-01
Completed	Clinical Evaluation of T.R.U.E. Test Allergens in Children an Adolescents Allergic Contact Dermatitis	N/A	2012-12-10
Withdrawn	Clinical Evaluation of T.R.U.E. TEST Panel 3.2 in Children and Adolescents Contact Dermatitis	Phase 3	2012-12-01
Completed	Bioequivalence of Ethylenediamine Dihydrochloride Study Allergic Contact Dermatitis	Phase 4	2012-07-01
Completed	Clinical Evaluation of T.R.U.E. TEST in Children and Adolescents Dermatitis, Contact	Phase 4	2008-11-01
Completed	Clinical Evaluation of T.R.U.E. TEST® Panel 3.2 Allergens: Dose Response Contact Dermatitis	Phase 2	2008-04-01
Completed	Clinical Evaluation of T.R.U.E. TEST® : Safety and Efficacy Contact Dermatitis	Phase 3	2008-04-01
Completed	Clinical Evaluation of T.R.U.E. TEST® Fragrance Mix and Thimerosal Allergens:Bioequivalence of PVP Formulation Dermatitis, Contact	Phase 2	2008-01-01